Eric Guenzi

2.2k citations

27 papers · 1.8k indexed · 1 hit paper · h-index 16

Impact in

Hepatology top 2%
- Hepatitis C virus research
Microbiology top 5%

Papers in

Molecular Medicine 3
- Antibiotic Resistance in Bacteria 3
Immunology 11
- Biosimilars and Bioanalytical Methods 7
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2

Co-authors: Regine Hakenbeck Michel Sicard Ingeborg Grgurina Guido Grandi G. Galli Dennis C. Gross Geneviève Alloing Miguel Cámara
Journals: Annals of the Rheumatic Diseases (2 papers)The EMBO Journal (2 papers)Expert Opinion on Biological Therapy (2 papers)Journal of Biological Chemistry (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: Germany United States Italy

In The Last Decade

Eric Guenzi

27 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. 1996 · 305 citations

Peers

Countries citing papers authored by Eric Guenzi

Since Specialization

Citations

This map shows the geographic impact of Eric Guenzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Guenzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Guenzi more than expected).

Fields of papers citing papers by Eric Guenzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Guenzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Guenzi. The network helps show where Eric Guenzi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eric Guenzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Guenzi Line = papers co-authored together Eric Guenzi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ex vivo comparative immunogenicity assessment (EVCIA) to determine relative immunogenicity in chronic plaque psoriasis in participants receiving Humira® or undergoing repeated switches between Humira® and AVT02 PubMed ·Kathleen Richter, М. Михайліченко, 武庄田, 英之中谷, Leonel Figueiredo de Alencar, Eric Guenzi, Fausto Berti	2023	1
2	Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study BMC Medical Research Methodology ·М. Михайліченко, Fausto Berti, 敦栗原, Eric Guenzi, Felipe M. Freire Pontes, E. Knopp, Ulrich Mansmann	2022	1
3	Assessment of real-life patient handling experience of AVT02 administered subcutaneously via autoinjector in patients with moderate to severe active rheumatoid arthritis: an open-label, single-arm clinical trial, then an extension phase of AVT02 administered with a prefilled syringe Expert Opinion on Biological Therapy ·Nemanja Damjanov, Chu-Ying Peng, Tiago Borchartt, Fausto Berti, Matjaz Steiger, Iwasa Fuyuki, Eric Guenzi, Felipe M. Freire Pontes, E. Knopp, М. Михайліченко, Ann M. Steves, 敦栗原	2022	2
4	AB1586-PARE MULTI-CENTER, RANDOMIZED, OPEN-LABEL, 2-ARM PARALLEL STUDY TO COMPARE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF AVT02 ADMINISTERED SUBCUTANEOUSLY VIA PREFILLED SYRINGE OR AUTOINJECTOR IN HEALTHY ADULT VOLUNTEERS Annals of the Rheumatic Diseases ·Jessica Jadira Bajaña Laje, 敦栗原, Jon P Mason, Chuan-Chong Chen, Eric Guenzi, Felipe M. Freire Pontes, E. Knopp, М. Михайліченко, Jeff Olin, Fausto Berti	2022	3
5	Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study BioDrugs ·Steven R. Feldman, Leonel Figueiredo de Alencar, Grażyna Pulka, Külli Kingo, Sien-Huei LiaoRadiographer, Fausto Berti, Iwasa Fuyuki, Aecio Neves Cunha, Eric Guenzi, Felipe M. Freire Pontes, М. Михайліченко, Richard Kay, 敦栗原	2021	22
6	Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration Proceedings of the National Academy of Sciences ·Yun Dong, Roman Fischer, Petrus J.W. Naudé, Olaf Maier, Csaba Nyakas, Maëlle Duffey, Eddy A. van der Zee, Doortje Dekens, M. Cierpka, Andreas Herrmann, Eric Guenzi, Roland E. Kontermann, Klaus Pfizenmaier, Ulrich Eisel	2016	123
7	Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity PLoS ONE ·Fabian Richter, Ian van Haaren, Eric Guenzi, Andreas Herrmann, Peter Scheurich, Klaus Pfizenmaier, Roland E. Kontermann	2013	34
8	In vivo imaging of choroidal angiogenesis using fluorescence-labeled cationic liposomes. PubMed ·Jing Hua, Nikolai Gross, B. Schulze, Uwe Michaelis, H Bohnenkamp, Eric Guenzi, Lutz L. Hansen, Gottfried Martin, Hansjürgen Agostini	2012	20
9	Comparison of lung accumulation of cationic liposomes in normal rats and LPS-treated rats Inflammation Research ·Susanne Herber-Jonat, Rashmi A. Mittal, Kan Shimizu, H Bohnenkamp, Eric Guenzi, Andreas Schulze	2010	19
10	Vascular targeting by EndoTAG™‐1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer International Journal of Cancer ·Martin Eichhorn, Ivan Ischenko, Lucía Irene Alzaga Magalia, Sebastian Strieth, A. Papyan, Alexander Werner, H Bohnenkamp, Eric Guenzi, Gerhard Preißler, Uwe Michaelis, Karl‐Walter Jauch, Christiane J. Bruns, Marc Dellian	2009	69
11	Maternal HIV Type 1 Infection Suppresses MMP-1 Expression in Endothelial Cells of Uninfected Newborns: Nonviral Vertical Transmission of HIV Type 1-Related Effects AIDS Research and Human Retroviruses ·Raspe, Thomas Grubert, Thomas W. Grimm, Eric Guenzi, Elisabeth Naschberger, Molly Endicott, Robert A.J. Oostendorp, Ulrich Keller, Michael Stürzl	2005	4
12	The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression The EMBO Journal ·Eric Guenzi	2003	125
13	Guanylate-Binding Protein-1 Expression Is Selectively Induced by Inflammatory Cytokines and Is an Activation Marker of Endothelial Cells during Inflammatory Diseases American Journal Of Pathology ·Clara Lubeseder–Martellato, Eric Guenzi, Raspe, Rein Nuissl Ekkehard Von, Elisabeth Naschberger, Elisabeth Kremmer, Christian Zietz, Erwin Tschachler, Peter Hutzler, Martin Schwemmle, K. Matzen, Thomas W. Grimm, Barbara Ensoli, Michael Stürzl	2002	126
14	The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines The EMBO Journal ·Eric Guenzi	2001	155
15	Coordinate Transcription and Physical Linkage of Domains in Surfactin Synthetase Are Not Essential for Proper Assembly and Activity of the Multienzyme Complex Journal of Biological Chemistry ·Eric Guenzi, G. Galli, Ingeborg Grgurina, Victoria R. Meldrum, Pasquale Ferranti, Guido Grandi	1998	26
16	Characterization of the Syringomycin Synthetase Gene Cluster Journal of Biological Chemistry ·Eric Guenzi, G. Galli, Ingeborg Grgurina, Dennis C. Gross, Guido Grandi	1998	149
17	Resistance Determinants for β-Lactam Antibiotics in Laboratory Mutants of Streptococcus pneumoniae That Are Involved in Genetic Competence Microbial Drug Resistance ·Dorothea Zähner, Thorsten Grebe, Eric Guenzi, 陈燕, Mark van der Linden, Kristin Øye Gjersdal, Jeffry B. Stock, Regine Hakenbeck	1996	22
18	A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proceedings of the National Academy of Sciences ·Domenico Rosa, Susanna Campagnoli, Cristiane Moretto, Eric Guenzi, Leslie P. Cousens, E. Dobnik, Christine Dong, Amy J. Weiner, Johnson Y.N. Lau, Q L Choo, David Chien, Piero Pileri, Michael Houghton, Sergio Abrignani Hit paper breakdown →	1996	305
19	A two‐component signal‐transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae Molecular Microbiology ·Eric Guenzi, Caitlin C. Bell, Michel Sicard, Regine Hakenbeck	1994	167
20	A highly conserved repeated DNA element located in the chromosome ofStreptococcus pneumoniae Nucleic Acids Research ·Bernard Martin, Odile Humbert, Miguel Cámara, Eric Guenzi, John Walker, Timothy J. Mitchell, Peter W. Andrew, Marc Prudhomme, Geneviève Alloing, Regine Hakenbeck, Donald A. Morrison, Graham J. Boulnois, Jean‐Pierre Claverys	1992	297

About Eric Guenzi

Eric Guenzi is a scholar working on Molecular Medicine, Immunology, Immunology and Allergy, Microbiology and Cancer Research, having authored 27 papers that have together received 1.8k indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (7 papers), Pneumonia and Respiratory Infections (5 papers), Pharmaceutical studies and practices (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Antibiotic Resistance in Bacteria (3 papers), Protease and Inhibitor Mechanisms (3 papers), Cell Adhesion Molecules Research (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Hepatology (294 citations), Microbiology (123 citations), Immunology (396 citations), Molecular Medicine (93 citations) and Epidemiology (501 citations). Eric Guenzi has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Regine Hakenbeck, Michel Sicard, Ingeborg Grgurina, Guido Grandi, G. Galli, Dennis C. Gross, Geneviève Alloing, Miguel Cámara, Odile Humbert and Bernard Martin. Their work appears in journals such as Annals of the Rheumatic Diseases, The EMBO Journal, Expert Opinion on Biological Therapy, Journal of Biological Chemistry and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact